TY  - JOUR
AU  - Díaz, Caridad
AU  - Pérez Del Palacio, José
AU  - Valero-Guillén, Pedro Luis
AU  - Mena García, Patricia
AU  - Pérez, Irene
AU  - Vicente, Francisca
AU  - Martín, Carlos
AU  - Genilloud, Olga
AU  - Sánchez Pozo, Antonio
AU  - Gonzalo-Asensio, Jesús
PY  - 2019
DO  - 10.1021/acsinfecdis.9b00008
UR  - http://hdl.handle.net/10668/13975
T2  - ACS infectious diseases
AB  - MTBVAC is a live attenuated M. tuberculosis vaccine constructed by genetic deletions in the phoP and fadD26 virulence genes. The MTBVAC vaccine is currently in phase 2 clinical trials with newborns and adults in South Africa, one of the countries with...
LA  - en
KW  - live attenuated vaccine
KW  - phoP
KW  - phosphatidylinositol mannosides
KW  - vaccination biomarkers
KW  - virulence
KW  - Bacterial Proteins
KW  - Biosynthetic Pathways
KW  - Chromatography, Liquid
KW  - Mass Spectrometry
KW  - Metabolomics
KW  - Mycobacterium tuberculosis
KW  - Phosphatidylinositols
KW  - Tuberculosis Vaccines
TI  - Comparative Metabolomics between Mycobacterium tuberculosis and the MTBVAC Vaccine Candidate.
TY  - research article
VL  - 5
ER  -